Brill, Margreke J <br/><br/>
The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery.  [electronic resource] 

 -  Pharmaceutical research  Dec 2015 
 - 3927-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-904X 
<br/><br/><label>Standard No.: </label>10.1007/s11095-015-1752-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Administration, Oral<br/>Adult<br/>Anti-Anxiety Agents--administration & dosage<br/>Bariatric Surgery<br/>Cohort Studies<br/>Cytochrome P-450 CYP3A--metabolism<br/>Female<br/>Humans<br/>Liver--metabolism<br/>Male<br/>Midazolam--administration & dosage<br/>Middle Aged<br/>Obesity, Morbid--blood<br/>Prospective Studies